Prostate Cancer Research Program
The multidisciplinary Prostate Cancer Research Program (PCRP) was established in 1996 by Andrew C. von Eschenbach, MD, Director, and Co-Directors Christopher J. Logothetis, MD, and Isaiah J. Fidler, DVM, PhD, on the premise that knowledge of the biology of disease (prostate cancer) is the foundation of therapy.
The current Director of the PCRP, Dr. Logothetis, is supported by a cross-institutional, multidisciplinary Executive Committee. The Committee is responsible for establishing the research direction of the PCRP and ensuring funding is aligned with our mission:
- Research infrastructure that can be reliably measured
- Grant support for those project aspects that are otherwise overlooked in the competitive grant environment
- Support for young faculty that can be leveraged into extramural grants and awards
The breadth of expertise on the Executive Committee has encouraged productive collaborations in prostate cancer, including new and refined basic and translational research, efficient clinical trials, drug development, successful grant competition, and publications.
Executive Committee Members (February 2009)
Donald Berry, PhD
Bogdan A. Czerniak, MD, PhD
Colin P. N. Dinney, MD
Mien-Chie Hung, PhD
Yong-Jun Liu, MD, PhD
Christopher Logothetis, MD
Gordon Mills, MD, PhD
Garth Powis, DPhil
Margaret R. Spitz, MD, MPH
Timothy C. Thompson, PhD
An Advisory Board composed of business and community leaders who are advocates of prostate cancer research oversees the fiscal function of the PCRP.